XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.2

COMMON STOCK OPTIONS AND WARRANTS (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2023

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Options Activity

Schedule of stock option issuance of shares
										Weighted
						Weighted				Average
						Average				Remaining				Aggregate
		Number of				Exercise				Contractual				Intrinsic
		Options				Price				Term (Years)				Value
Outstanding at December 31, 2021			431,266			$	4.98				3.4				—
Granted			685,000			$	6.41				4.0				—
Forfeited			(190,000	)		$	6.41				—				—
Outstanding at December 31, 2022			926,266			$	5.74				3.3				—
Exercisable at December 31, 2022			404,599			$	5.02				3.3				—
Outstanding at December 31, 2022			926,266			$	5.74				3.3				—
Granted			—				—				—				—
Exercised/Forfeited/Expired			(1,608	)		$	14.00				—				—
Outstanding at March 31, 2023			924,658			$	5.73				3.0				—
Exercisable at March 31, 2023			574,658			$	5.36				3.0				—

Schedule of Options Activity
										Weighted
						Weighted				Average
						Average				Remaining				Aggregate
						Exercise				Contractual				Intrinsic
		Shares				Price				Term (Years)				Value
Outstanding at December 31, 2020			451,898			$	5.06				4.2				—
Granted			20,000			$	4.32				4.0				—
Forfeited			(40,632	)		$	14.00				—				—
Outstanding at December 31, 2021			431,266			$	4.98				3.4			$	197,506
Exercisable at December 31, 2021			312,310			$	5.25				3.4				—
Outstanding at December 31, 2021			431,266			$	4.98				3.4				—
Granted			685,000			$	6.41				4.0				—
Exercised/Forfeited			(190,000	)		$	6.41				—				—
Outstanding at December 31, 2022			926,266			$	5.74				3.3			$	0
Exercisable at December 31, 2022			404,599			$	5.02				3.3				—

Schedule of Fair Value Assumptions

Schedule of Fair Value Assumptions
		For the Years Ended December 31,
		2022		2021
Risk free interest rate		0.97 – 3.15%		0.18%
Expected term in years		3.25 - 3.50		3.50
Dividend yield		—		—
Volatility of common stock		72-80%		91.6%

Schedule of Warrants Outstanding

Schedule of Warrants Outstanding
										Weighted
						Weighted				Average
						Average				Remaining				Aggregate
		Number of				Exercise				Contractual				Intrinsic
		Warrants				Price				Term (Years)				Value
Outstanding at December 31, 2021			1,376,466			$	8.18				1.9				—
Warrants expired, forfeited, cancelled or exercised			(1,228,875	)			—				—				—
Warrants issued			—				—				—				—
Outstanding at December 31, 2022			147,591			$	8.63				0.8				—
Exercisable at December 31, 2022			147,591			$	8.63				0.8				—
Outstanding at December 31, 2022			147,591			$	8.63				0.8				—
Warrants expired, forfeited, cancelled or exercised			(67,500	)			—				—				—
Warrants issued			—				—				—				—
Outstanding at March 31, 2023			80,091			$	8.53				1.1				—
Exercisable at March 31, 2023			80,091			$	8.53				1.1				—

Schedule of Warrants Outstanding
										Weighted
						Weighted				Average
						Average				Remaining				Aggregate
		Number of				Exercise				Contractual				Intrinsic
		Warrants				Price				Term (Years)				Value
Outstanding at December 31, 2020			1,587,553			$	8.62				2.0				—
Warrants expired, forfeited, cancelled or exercised			(232,517	)
Warrants issued			21,430			$	7.70				1.9				—
Outstanding at December 31, 2021			1,376,466			$	8.18				1.9				—
Exercisable at December 31, 2021			1,376,466			$	8.18				1.9				—
Outstanding at December 31, 2021			1,376,466			$	8.18				1.9				—
Warrants expired, forfeited, cancelled or exercised			(1,228,875	)							—
Warrants issued			0			$	—				—				—
Outstanding at December 31, 2022			147,591			$	8.63				0.8				—
Exercisable at December 31, 2022			147,591			$	8.63				0.8				—

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration